Celltrion receives MHRA approval to initiate Phase I trial of potential COVID-19 antiviral antibody treatment, CT-P59, in the UK
The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved Celltrion’s clinical trial authorization (CTA) application to initiate a Phase...






